arrow
C

Costa Bachas

vrije universiteit amsterdam
H指数:16
被引数:1,462

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies

高危MDS患者经强化疗后可测量残留疾病的预后价值:HOVON-SAKK研究

2026-05-210
OAAI
Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy

基于流式细胞术的可测量残留病灶评估在接收非强化化疗的急性髓系白血病患者中的应用

2026-03-190
PREAI
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia

流式细胞术基线可测残留病评估中定量下限作为低水平截断值的预后相关性研究

Leukemia
IF13.4
2025-12-100
OA
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial

急性髓系白血病中的计算性微小残留病评估:一项在HOVON-SAKK-132试验中的回顾性验证

Leukemia
IF13.4
2025-09-030
OAAI
Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival

中等风险急性髓系白血病患者中可测量的残留疾病引导治疗是减少异基因移植而不影响生存的有价值的策略

2023-04-0612
OAAI
Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis
2022-10-103
OAAI